Archive - Innovation Observer

Harpoon Therapeutics Acquisition by Merck

T-cell engagers & Merck’s portfolio in the wake of Keytruda's looming patent expiry

Jan 16 •

February 2023

Who captures the most value in the AI explosion?

Applications vs. Knowledge vs. Models vs. Infrastructure

Feb 7, 2023 •

January 2023

How companies generate inefficiency through misuse of OKRs

Jan 23, 2023 •

April 2022

Tribe Capital’s N-of-1 Philosophy

Subverting the Khosla Dilemma

Apr 11, 2022 •

January 2022

MEFO Bills, Inflation, and Cryptocurrencies

2022 - An Uncertain Era of Macroeconomic Policy

Jan 12, 2022 •

Chipax | Company Profile Q1 2022

Overview: Chipax, QuickBooks for SMBs in LatAm Chipax is a software-as-a-service venture that is building a full-stack payments, invoicing, and…

Jan 7, 2022 •

November 2021

Defining a Problem Space

Nov 15, 2021 •

The Issues with "Democratizing" an Industry Through Software

The Creator Economy & Pareto Returns

Nov 8, 2021 •

Early-Stage Innovation: Roadmap for an early-stage software venture

Nov 1, 2021 •

April 2021

Attractiveness, Aptitude, and Alcoholism

The Curiosity of the Pareto Distribution in Returns to Human Capital

Apr 9, 2021 •

Schumpeter’s Entrepreneur

Modeling the Role of the Entrepreneur in an Economy

Apr 2, 2021 •

March 2021

Monthly Roundup | Mar

A monthly roundup of compact ideas, thoughts, companies, and micro-theses to consider.

Mar 5, 2021 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts